Related references
Note: Only part of the references are listed.Bexarotene Enhances Macrophage Erythrophagocytosis and Hematoma Clearance in Experimental Intracerebral Hemorrhage
Che-Feng Chang et al.
STROKE (2020)
Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Current Research in Melanoma and Aggressive Nonmelanoma Skin Cancer
Reason Wilken et al.
FACIAL PLASTIC SURGERY (2020)
Cellular backpacks for macrophage immunotherapy
C. Wyatt Shields et al.
SCIENCE ADVANCES (2020)
High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
Natasha Vinod et al.
SCIENCE ADVANCES (2020)
Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function
Anvay Ukidve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy
Jingjing Sun et al.
THERANOSTICS (2020)
Macrophage-Mediated Delivery of Hypoxia-Activated Prodrug Nanoparticles
Michael A. Evans et al.
ADVANCED THERAPEUTICS (2020)
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
Kayo Tanita et al.
FRONTIERS IN ONCOLOGY (2019)
Novel Targets for the Treatment of Melanoma
Lara Ambrosi et al.
CURRENT ONCOLOGY REPORTS (2019)
Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation
Ines Mottas et al.
BIOMATERIALS (2019)
TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy
Lingyun Xia et al.
CELL METABOLISM (2019)
Inflammation and Hypoxia: HIF and PHD Isoform Selectivity
Emily R. Watts et al.
TRENDS IN MOLECULAR MEDICINE (2019)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer
Ashish Kulkarni et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages
Julio M. Rios de la Rosa et al.
ADVANCED HEALTHCARE MATERIALS (2017)
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
Douglas R. Vogus et al.
JOURNAL OF CONTROLLED RELEASE (2017)
HIF1 alpha-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages
Ting Wang et al.
MEDIATORS OF INFLAMMATION (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Targeting tumor associated macrophages: The new challenge for nanomedicine
Fernando Torres Andon et al.
SEMINARS IN IMMUNOLOGY (2017)
Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging
Michael F. Cuccarese et al.
NATURE COMMUNICATIONS (2017)
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
Huju Chi et al.
FRONTIERS IN PHARMACOLOGY (2017)
Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment
Yi Wang et al.
BIOMATERIALS (2017)
A review on engineering polymer drug conjugates to improve combination chemotherapy
Douglas R. Vogus et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2017)
Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages
Yuan Qian et al.
ACS NANO (2017)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma
Jared Klarquist et al.
CANCER RESEARCH (2016)
Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates
Li Li et al.
DRUG DELIVERY (2016)
Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
Joao Conde et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides
Hiroyuki Shinchi et al.
BIOCONJUGATE CHEMISTRY (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid
Kathryn M. Camacho et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy
Shiying Luo et al.
MOLECULAR PHARMACEUTICS (2015)
Nanoparticle-mediated drug delivery for treating melanoma
Vaibhav Mundra et al.
NANOMEDICINE (2015)
Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer
Vincenzo Bronte et al.
NATURE MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles
Thanh-Huyen Tran et al.
SCIENTIFIC REPORTS (2015)
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs
Ela Markovsky et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Systemic cancer immunotherapy with Toll-like receptor 7 agonists Timing is everything
Christian Hotz et al.
ONCOIMMUNOLOGY (2012)
Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
Carole Bourquin et al.
CANCER RESEARCH (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
Abbi L Engel et al.
Expert Review of Clinical Pharmacology (2011)
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers
Twan Lammers et al.
BIOMATERIALS (2009)
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
Evelien L. J. M. Smits et al.
ONCOLOGIST (2008)
被撤回的出版物: The role of nitric oxide in inflammatory reactions (Retracted article. See vol. 66, pg. 449, 2012)
Parul Tripathi et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene
Donald E. Tsai et al.
CANCER BIOLOGY & THERAPY (2007)
Share Paper
